Exactly that is the problem with MCU!!! Medicure has perhaps the most promising pipeline in cardiovascular drug development, but a partnership is necessary to add credibility to the MC-1 development program!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.